Elevance Health Inc (ELV · NYSE)

ELV · MARKET VIEW

Market view · as of Jul 27, 2026

Revenue (TTM)
$201.11B
+1.4% YoY
Gross margin
26.0%
EPS (latest q)
$7.45
vs $6.18 est · beat
52-wk position
68.9%
-11.5% vs 52w high · -2.5% 1mo

Price (last ~year)

Elevance Health (ELV) reported Q2 2026 revenue of $50.47 billion and earnings per share of $7.45, marking the fourth consecutive quarter the company has exceeded analyst earnings estimates. The health benefits provider maintains a market capitalization of $81.91 billion, with a 2.5% profit margin and $31.04 billion in total debt. Shares recently traded at $377.68, down 5.5% from the 20-day simple moving average, alongside recent disclosures of insider share purchases by company leadership.

Valuation

Market cap
$81.91B
P/E
16.7
PEG
1.337
P/B
1.825
P/S
0.407
Beta
0.683
Analyst target
$449.1

Quality & returns

Gross margin
26.0%
Operating margin
4.6%
Profit margin
2.5%
ROE
11.1%
ROA
3.8%

Price movement

Last
$377.68
1-month
-2.5%
3-month
+4.6%
RSI (14)
38
vs SMA200
+8.5%
52-wk position
68.9% -11.5% vs high

Quarterly trajectory

Revenue by quarter (oldest → newest)

QuarterRevenueOp incomeNet incomeEBITDA
2026-06-30$50.47B$2.06B$1.46B$2.10B
2026-03-31$50.18B$2.66B$1.76B$2.77B
2025-12-31$49.75B$581.0M$547.0M$987.0M
2025-09-30$50.71B$1.76B$1.19B$2.14B

Recent news

Sources this view read

  • fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
  • filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
  • earnings Reported earnings history (Alpha Vantage EARNINGS)
  • prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)

Other snapshots